फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

firstmed theraconcept inc. - cefuroxime (as axetil) - film-coated tablet - 500mg

फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

pharex health corporation - cefuroxime (as axetil) - powder for suspension - 250mg/ 5ml

फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

philusa corporation - cefuroxime (as axetil) - tablet - 500 mg

फ़िलिपींस - अंग्रेज़ी - FDA (Food And Drug Administration)

actimed, inc - cefuroxime (as axetil) - powder for suspension - 125 mg/ 5 ml

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

app pharmaceuticals, llc - cefuroxime (unii: o1r9fj93ed) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 750 mg

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

app pharmaceuticals, llc - cefuroxime (unii: o1r9fj93ed) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 7.5 g in 80 ml

इसराइल - अंग्रेज़ी - Ministry of Health

vitamed ltd, israel - cefuroxime as sodium - powder for solution or suspension for injection or infusion - cefuroxime as sodium 750 mg - cefuroxime - cefuroxime – vit is indicated for the treatment of the infections listed below in adults and children, including neonates (from birth):• community acquired pneumonia• acute exacerbations of chronic bronchitis• complicated urinary tract infections, including pyelonephritis• soft-tissue infections: cellulitis, erysipelas and wound infections• intra-abdominal infections• prophylaxis against infection in gastrointestinal (including oesophageal), orthopaedic, cardiovascular, and gynaecological surgery (including caesarean section)• nose infections for example, sinusitis• septic arthritis

माल्टा - अंग्रेज़ी - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - cefuroxime - film-coated tablet - cefuroxime 250 mg - antibacterials for systemic use

माल्टा - अंग्रेज़ी - Medicines Authority

actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - cefuroxime - film-coated tablet - cefuroxime 500 mg - antibacterials for systemic use

संयुक्त राज्य - अंग्रेज़ी - NLM (National Library of Medicine)

a-s medication solutions - cefuroxime axetil (unii: z49qdt0j8z) (cefuroxime - unii:o1r9fj93ed) - cefuroxime 250 mg - cefuroxime axetil tablets are indicated for the treatment of adult patients and pediatric patients (13 years and older) with mild-to-moderate pharyngitis/tonsillitis caused by susceptible strains of streptococcus pyogenes. limitations of use - the efficacy of cefuroxime axetil in the prevention of rheumatic fever was not established in clinical trials. - the efficacy of cefuroxime axetil in the treatment of penicillin-resistant strains of streptococcus pyogenes has not been demonstrated in clinical trials. cefuroxime axetil tablets are indicated for the treatment of pediatric patients (who can swallow tablets whole) with acute bacterial otitis media caused by susceptible strains of streptococcus pneumoniae , haemophilus influenzae (including β-lactamase–producing strains), moraxella catarrhalis (including β-lactamase–producing strains), or streptococcus pyogenes . cefuroxime axetil tablets are indicated for the treatment of adult and pediatric patients (13 years and older) with mild-to-moderate acute bacte